Regenxbio Inc
NASDAQ:RGNX

Watchlist Manager
Regenxbio Inc Logo
Regenxbio Inc
NASDAQ:RGNX
Watchlist
Price: 13.51 USD 2.58% Market Closed
Market Cap: 683.9m USD

Wall Street
Price Targets

RGNX Price Targets Summary
Regenxbio Inc

Wall Street analysts forecast RGNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGNX is 32.09 USD with a low forecast of 14.14 USD and a high forecast of 54.6 USD.

Lowest
Price Target
14.14 USD
5% Upside
Average
Price Target
32.09 USD
138% Upside
Highest
Price Target
54.6 USD
304% Upside
Regenxbio Inc Competitors:
Price Targets
688177
Bio-Thera Solutions Ltd
60% Upside
002007
Hualan Biological Engineering Inc
25% Upside
603087
Gan & Lee Pharmaceuticals
0% Downside
7774
Japan Tissue Engineering Co Ltd
161% Upside
300896
Imeik Technology Development Co Ltd
40% Upside
688180
Shanghai Junshi Biosciences Co Ltd
25% Downside
EVAX
Evaxion Biotech A/S
119% Upside
URGN
Urogen Pharma Ltd
66% Upside

Revenue
Forecast

Revenue Estimate
Regenxbio Inc

For the last 10 years the compound annual growth rate for Regenxbio Inc's revenue is 30%. The projected CAGR for the next 4 years is 56%.

30%
Past Growth
56%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Regenxbio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Regenxbio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RGNX's stock price target?
Price Target
32.09 USD

According to Wall Street analysts, the average 1-year price target for RGNX is 32.09 USD with a low forecast of 14.14 USD and a high forecast of 54.6 USD.

What is Regenxbio Inc's Revenue forecast?
Projected CAGR
56%

For the last 10 years the compound annual growth rate for Regenxbio Inc's revenue is 30%. The projected CAGR for the next 4 years is 56%.

Back to Top